DK1853284T3 - Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum - Google Patents

Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum

Info

Publication number
DK1853284T3
DK1853284T3 DK06705161.5T DK06705161T DK1853284T3 DK 1853284 T3 DK1853284 T3 DK 1853284T3 DK 06705161 T DK06705161 T DK 06705161T DK 1853284 T3 DK1853284 T3 DK 1853284T3
Authority
DK
Denmark
Prior art keywords
synbiotic
probiotic
lactobacillus kefiranofaciens
kefiranofaciens
lactobacillus
Prior art date
Application number
DK06705161.5T
Other languages
English (en)
Inventor
Louis-Philippe Precourt
Eric Simard
Pierre Lemieux
Original Assignee
Biolactis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolactis Inc filed Critical Biolactis Inc
Application granted granted Critical
Publication of DK1853284T3 publication Critical patent/DK1853284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06705161.5T 2005-02-11 2006-02-10 Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum DK1853284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65165705P 2005-02-11 2005-02-11
PCT/CA2006/000206 WO2006084381A1 (en) 2005-02-11 2006-02-10 Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic

Publications (1)

Publication Number Publication Date
DK1853284T3 true DK1853284T3 (da) 2014-07-14

Family

ID=36792883

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06705161.5T DK1853284T3 (da) 2005-02-11 2006-02-10 Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum

Country Status (8)

Country Link
US (2) US20090130072A1 (da)
EP (1) EP1853284B1 (da)
JP (2) JP5401733B2 (da)
CA (1) CA2597229A1 (da)
DK (1) DK1853284T3 (da)
ES (1) ES2496965T3 (da)
MX (1) MX2007009659A (da)
WO (1) WO2006084381A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214253A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
WO2009043171A1 (en) * 2007-10-02 2009-04-09 Institut National De La Recherche Scientifique Method of regulating the th17 pathway and its associated metabolic impact
JP2010037225A (ja) * 2008-08-01 2010-02-18 Nippon Kefia Kk 乳清ケフィアを有効成分として含んでなる体脂肪減少剤
JP2012034616A (ja) * 2010-08-06 2012-02-23 Umeya Co Ltd 塩たらこの製造方法及び塩たらこ、並びに辛子明太子の製造方法及び辛子明太子
JP5840368B2 (ja) 2011-02-02 2016-01-06 カルピス株式会社 関節炎予防改善用物質
KR101779719B1 (ko) 2016-08-30 2017-09-19 건국대학교 산학협력단 신규한 락토바실러스 케피아노파시엔스 dn1 균주 및 이를 포함하는 변비의 예방 또는 치료용 조성물
CN106937745A (zh) * 2016-08-31 2017-07-11 快醒生物科技（北京）有限公司 一种具有改善肠道功能的保健品及其制备方法
EP3546566A4 (en) * 2016-11-01 2020-05-27 Keio University TH1 CELL INDUCTION BACTERIA
KR102089938B1 (ko) * 2016-12-21 2020-03-17 (주)프로스테믹스 케피어 그레인 유래 미세소포체의 용도
KR101930143B1 (ko) * 2016-12-21 2018-12-17 건국대학교 산학협력단 유산균 유래 세포외다당류를 함유하는 항균 조성물
JP2019034924A (ja) * 2017-08-10 2019-03-07 株式会社Ｎｒｌファーマ 妊娠中の母子の健康状態改善剤
US10632161B1 (en) 2019-05-23 2020-04-28 Prostemics Co. Ltd. Method for ameliorating or treating a bowel disease
CN111575202A (zh) * 2020-05-19 2020-08-25 北京科拓恒通生物技术股份有限公司 一株用于预防辅助治疗ⅱ型糖尿病的干酪乳杆菌及其应用
CN111808910A (zh) * 2020-07-22 2020-10-23 南京农业大学 一种评价膳食多糖活性的方法
KR20220061555A (ko) * 2020-11-06 2022-05-13 (주)프로스테믹스 신규한 락토바실러스 속 균주 및 상기 균주 유래 세포외 소포의 용도
CN114805474B (zh) * 2022-04-02 2024-03-22 中国海洋大学 一株干酪乳杆菌fn345及其在制备预防辅食期婴儿腹泻菌剂中的应用
CN116948916B (zh) * 2023-08-11 2024-06-11 四川大学 一种干酪乳杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
JPH05301812A (ja) * 1992-04-23 1993-11-16 Sansho Seiyaku Co Ltd 皮膚外用剤
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
JP2002330798A (ja) * 2001-05-11 2002-11-19 Yamato Yakuhin Kk 多糖製造方法
US20060057131A1 (en) * 2001-12-20 2006-03-16 Eric Simard Malleable protein matrix and uses thereof

Also Published As

Publication number Publication date
EP1853284A4 (en) 2012-03-21
ES2496965T3 (es) 2014-09-22
JP5401733B2 (ja) 2014-01-29
JP2008530034A (ja) 2008-08-07
US20140193383A1 (en) 2014-07-10
WO2006084381A1 (en) 2006-08-17
EP1853284A1 (en) 2007-11-14
MX2007009659A (es) 2008-01-16
EP1853284B1 (en) 2014-04-09
CA2597229A1 (en) 2006-08-17
US20090130072A1 (en) 2009-05-21
JP2013139462A (ja) 2013-07-18

Similar Documents

Publication Publication Date Title
DK1853284T3 (da) Anvendelse af Lactobacillus kefiranofaciens som probiotikum og synbiotikum
DE602006010723D1 (de) Neues bakterium der gattung bifidobacterium und dessen nutzung
BRPI0810087A2 (pt) Cepas de bifidobacterium probióticas
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
DK1723128T3 (da) Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
DK2318513T3 (da) Ny probiotisk bifidobacterium longum
DK2115114T3 (da) Rengøringsenzymer og forebyggelse af ildelugt
DK2308900T3 (da) Immunogene sammensætninger og fremgangsmåder til anvendelse
DK1880001T3 (da) Feline probiotiske lactobacilli
DK2074205T3 (da) Detergentsammensætninger og anvendelsen af enzymkombinationer deri
BRPI0813318A2 (pt) implante pélvico, e, kit
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
EP2232003A4 (en) BRECHFLUIDE AND USE METHOD THEREFOR
DK1937824T3 (da) Sammensætninger af tRNA og anvendelser deraf
DK2137304T3 (da) Delta-9-elongaser og anvendelser heri i fremstillingen af flerumættedefedtsyrer
IL188680A0 (en) Microfluidic devices and methods of preparing and using the same
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
EP2032086A4 (en) WASHER MOVEMENT DEVICES AND APPLICATION METHOD
DK2136825T3 (da) Anvendelse af Lactobacillus plantarum til forøgelse af bakteriediversiteten
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
EP2153345A4 (en) PROVISION OF ROUTE INFORMATION BETWEEN VARIOUS APPLICATION INFORMATION AND USE OF THE ROUTE INFORMATION
EP2021555A4 (en) STRUCTURAL ELEMENT AND METHODS OF USE THEREOF
GB0719577D0 (en) Microimplant devices and methods of making and use thereof
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse